ArticleBMC pulmonary medicine2020
Prognostic factors for survival after bronchoscopic intervention in patients with airway obstruction due to primary pulmonary malignancy.
Article in BMC pulmonary medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 28 citations in OpenAlex.
- Outcomes and Prognostic Analysis of Therapeutic Bronchoscopy in Non-Small Cell Lung Cancer (NSCLC) Patients With Respiratory Failure Secondary to Malignant Central Airway Obstruction (MCAO).Pulmonary medicine · 2026Article
- Fire: argon plasma coagulation, diathermy and laser.Breathe (Sheffield, England) · 2025Review
- Prognostic factors and clinical outcomes of stenting on malignant central airway obstruction.Scientific reports · 2025Article
- Interventional bronchoscopy in lung cancer treatment.Breathe (Sheffield, England) · 2024Review
- The role of interventional bronchoscopy in the management of malignant central airway obstruction.Respiratory medicine case reports · 2024Article
- Trends and an Online Survey on the Use of Rigid Bronchoscopy in Korea.Journal of Korean medical science · 2023Article
- Extracorporeal membrane oxygenation in critical airway interventional therapy: A review.Frontiers in oncology · 2023Review
- Review of the clinical outcomes of therapeutic bronchoscopy for central airway obstruction.Mediastinum (Hong Kong, China) · 2023Review
- First-In-Human Computer-Optimized Endobronchial Ultrasound-Guided Interstitial Photodynamic Therapy for Patients With Extrabronchial or Endobronchial Obstructing Malignancies.JTO clinical and research reports · 2022Article
- Therapeutic bronchoscopy in malignant central airway obstruction: is technical success always clinically relevant?Journal of thoracic disease · 2022Article
- Does airway metallic stent limit additional treatments in patients with malignant airway stenosis?General thoracic and cardiovascular surgery · 2022Article
- Predictors of survival and technical success of bronchoscopic interventions in malignant airway obstruction.Journal of thoracic disease · 2021Article
- Survival and prognostic factors for patients with malignant central airway obstruction following airway metallic stent placement.Journal of thoracic disease · 2021Article
- External Beam Radiotherapy for Malignant Central Airway Obstruction in a Remote Rural Patient: A Case Study.Case reports in oncologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMalignant central airway obstruction (MCAO) occurs in 20-30% of patients with primary pulmonary malignancy. Although bronchoscopic intervention is widely performed to treat MCAO, little data exist on the prognosis of interventional bronchoscopy. Therefore, we evaluated the clinical outcomes and prognostic factors of bronchoscopic interventions in patients with MCAO due to primary pulmonary malignancy.
methodsThis retrospective study was conducted at a university hospital and included 224 patients who received interventional bronchoscopy from 2004 to 2017, excluding patients with salivary gland-type tumor. A multivariable Cox proportional hazard regression analysis was used to identify independent prognostic factors associated with survival after the first bronchoscopic intervention.
resultsAmong 224 patients, 191 (85.3%) were males, and the median age was 63 years. The most common histological type of malignancy was squamous cell carcinoma (71.0%). Technical success was achieved in 93.7% of patients. Acute complications and procedure-related death occurred in 15.6 and 1.3% of patients, respectively. The median survival time was 7.0 months, and survival rates at one year and two years were 39.7 and 28.3%, respectively. Poor survival was associated with underlying chronic pulmonary disease, poor performance status, extended lesion, extrinsic or mixed lesion, and MCAO due to disease progression and not receiving adjuvant treatment after bronchoscopic intervention.
conclusionsInterventional bronchoscopy could be a safe and effective procedure for patients who have MCAO due to primary pulmonary malignancy. In addition, we found several prognostic factors for poor survival after intervention, which will help clinicians determine the best candidates for bronchoscopic intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.